Literature DB >> 19088448

Entrapment of embryonic stem cells-derived cardiomyocytes in macroporous biodegradable microspheres: preparation and characterization.

Abdulrhman A Akasha1, Isaia Sotiriadou, Michael X Doss, Marcel Halbach, Johannes Winkler, Jennifer J S Baunach, Alisa Katsen-Globa, Heiko Zimmermann, Yen Choo, Jurgen Hescheler, Agapios Sachinidis.   

Abstract

Embryonic Stem (ES) cells-derived cardiomyocytes can possibly be applied for cell therapy of diseases such as heart failure. Biodegradable scaffolds will significantly improve the expansion of sufficient functional ES cell-derived cardiomyocytes and may also increase the survival rate of cardiomyocytes after their transplantation. In the present study, we cultivated cardiomyocytes isolated from a transgenic a-myosin heavy chain (alpha-MHC) ES cell lineage expressing both puromycin resistance and enhanced green fluorescent protein (EGFP) under the control of the alpha-MHC promoter in macroporous gelatine microspheres using small-scale bioreactors and proved that cardiomyocytes function after their cultivation in micropsperes. The average number of cultivated cells per microsphere was optimised once the most suitable agitation conditions and the optimal timeframe of cultivation were identified. Our study shows that 72% of CultiSpher-S beads were colonised by cardiomyocytes under optimal conditions. Scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) showed that colonization of the beads was not limited to the surface, but that cells also invaded the inner surfaces of the microspheres. Electrophysiological experiments demonstrated that the action potentials (APs) of alpha-MHC(+) cardiomyocytes entrapped in microspheres were identical to action potentials of control cells. This attractive approach for cultivation and expansion of functional cardiomyocytes in biodegradable macroporous may offer a perspective for higher transplantation efficiencies of ES cell-derived cardiomyocytes. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088448     DOI: 10.1159/000185550

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems.

Authors:  Donghui Jing; Abhirath Parikh; Emmanuel S Tzanakakis
Journal:  Cell Transplant       Date:  2010-06-29       Impact factor: 4.064

Review 2.  Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium.

Authors:  Joseph A Palatinus; J Matthew Rhett; Robert G Gourdie
Journal:  J Mol Cell Cardiol       Date:  2009-06-25       Impact factor: 5.000

Review 3.  Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.

Authors:  Daniel E Kehoe; Donghui Jing; Lye T Lock; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

4.  Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors.

Authors:  Sasitorn Rungarunlert; Mongkol Techakumphu; Melinda K Pirity; Andras Dinnyes
Journal:  World J Stem Cells       Date:  2009-12-31       Impact factor: 5.326

5.  All-trans-retinoid acid induces the differentiation of encapsulated mouse embryonic stem cells into GABAergic neurons.

Authors:  Cynthia Addae; Xiaoping Yi; Ramkishore Gernapudi; Henrique Cheng; Alberto Musto; Eduardo Martinez-Ceballos
Journal:  Differentiation       Date:  2012-03-30       Impact factor: 3.880

6.  Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly.

Authors:  Ying Wang; Prasanth Puthanveetil; Fang Wang; Min Suk Kim; Ashraf Abrahani; Brian Rodrigues
Journal:  Diabetes       Date:  2011-06-06       Impact factor: 9.461

7.  Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors.

Authors:  Dorothee Eicke; Anja Baigger; Kai Schulze; Sharissa L Latham; Caroline Halloin; Robert Zweigerdt; Carlos A Guzman; Rainer Blasczyk; Constança Figueiredo
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.